Skip Navigation



NDT Advance Access published online on May 9, 2008

Nephrology Dialysis Transplantation, doi:10.1093/ndt/gfn172
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Chan, K. E.
Right arrow Articles by Moran, J.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chan, K. E.
Right arrow Articles by Moran, J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author [2008]. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org



Facility factors dominate the ability to achieve target hemoglobin levels in hemodialysis patients

Kevin E. Chan1,*, Richard A. Lafayette1,*, Alice S. Whittemore2, Mark A. Hlatky2 and John Moran3

1 Division of Nephrology 2 Health Research and Policy Stanford University School of Medicine 3 Satellite Healthcare, CA, USA

Correspondence and offprint requests to: Kevin E. Chan, Division of Nephrology, Stanford University School of Medicine, 300 Pasteur Drive, S161, Stanford, CA 94305-5114, USA. Tel: +1-650-725-4738; E-mail: kevinchan9999{at}hotmail.com, czar{at}stanford.edu



  Abstract

Background. Our objective was to determine whether patient factors, processes of care and measures of erythropoietin (EPO) responsiveness were associated with successful anemia management at the individual patient level.

Methods. We retrospectively reviewed laboratory and demographic data from 1499 patients receiving hemodialysis in 15 units operated by the same dialysis provider. We performed univariate and multivariate logistic regression analysis to determine predictors of an average 3-month hemoglobin level below or above the target interval of 11.0–12.5 g/dL. To explain the effect of facility on anemia performance, we calculated correlations between measures of EPO responsiveness and the probability of achieving the target interval by facility.

Results. Patients above the target hemoglobin range demonstrated an association with parathyroid hormone (PTH) (OR = 0.96 per 100 pg/mL increase), female gender (OR = 0.68), EPO protocol use (OR = 0.94 per 10% increase in use) and facility (range of OR = 0.26–2.59 for 15 participating sites). Patients below the target hemoglobin range demonstrated an association with CRP (OR = 1.10 per mg/L increase), PTH (OR = 1.07 per 100 pg/mL increase), iron deficiency (OR = 1.07 per 10% increase), EPO protocol use (OR = 0.89 per 10% increase in use), iron protocol use (OR = 0.93 per 10% increase in use) and facility (range of OR = 0.58–3.41 over 15 units). EPO index (r = 0.71), EPO dose (r = 0.73), hemoglobin (r = –0.60) and EPO per unit weight (r = 0.76) were significantly correlated with the probability of achieving the target hemoglobin by facility.

Conclusions. The facility significantly influences the outcome of anemia management in patients with ESRD. In part, this is due to the patients’ EPO responsiveness, which may be influenced by facility care patterns.

Keywords: anemia management; ESRD; processes of care


* Kevin E. Chan and Richard A. Lafayette served as co-first authors on this manuscript.

Received for publication: 19.10.07
Accepted in revised form: 5. 3.08


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.